X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SHASUN PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SHASUN PHARMA J.B.CHEMICALS/
SHASUN PHARMA
 
P/E (TTM) x 17.2 123.9 13.9% View Chart
P/BV x 2.3 8.5 27.3% View Chart
Dividend Yield % 0.2 0.2 71.5%  

Financials

 J.B.CHEMICALS   SHASUN PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
SHASUN PHARMA
Mar-14
J.B.CHEMICALS/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs31894 337.7%   
Low Rs20046 437.5%   
Sales per share (Unadj.) Rs148.0214.2 69.1%  
Earnings per share (Unadj.) Rs19.15.3 357.7%  
Cash flow per share (Unadj.) Rs23.915.8 151.4%  
Dividends per share (Unadj.) Rs0.501.00 50.0%  
Dividend yield (eoy) %0.21.4 13.5%  
Book value per share (Unadj.) Rs128.953.3 241.7%  
Shares outstanding (eoy) m84.8256.62 149.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.3 535.9%   
Avg P/E ratio x13.613.1 103.5%  
P/CF ratio (eoy) x10.84.4 244.6%  
Price / Book Value ratio x2.01.3 153.2%  
Dividend payout %2.618.7 14.0%   
Avg Mkt Cap Rs m21,9513,958 554.6%   
No. of employees `0002.7NA-   
Total wages/salary Rs m1,8412,164 85.1%   
Avg. sales/employee Rs Th4,590.9NM-  
Avg. wages/employee Rs Th673.4NM-  
Avg. net profit/employee Rs Th592.1NM-  
INCOME DATA
Net Sales Rs m12,55112,127 103.5%  
Other income Rs m542229 236.1%   
Total revenues Rs m13,09312,356 106.0%   
Gross profit Rs m2,0551,009 203.6%  
Depreciation Rs m412594 69.5%   
Interest Rs m96415 23.1%   
Profit before tax Rs m2,088230 909.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469-73 -645.1%   
Profit after tax Rs m1,619302 535.8%  
Gross profit margin %16.48.3 196.7%  
Effective tax rate %22.5-31.7 -71.0%   
Net profit margin %12.92.5 517.7%  
BALANCE SHEET DATA
Current assets Rs m7,7786,884 113.0%   
Current liabilities Rs m4,3588,456 51.5%   
Net working cap to sales %27.2-13.0 -210.2%  
Current ratio x1.80.8 219.2%  
Inventory Days Days5562 88.7%  
Debtors Days Days80108 74.4%  
Net fixed assets Rs m5,7134,970 114.9%   
Share capital Rs m170113 149.7%   
"Free" reserves Rs m10,5472,875 366.9%   
Net worth Rs m10,9373,020 362.1%   
Long term debt Rs m01,817 0.0%   
Total assets Rs m15,57413,347 116.7%  
Interest coverage x22.81.6 1,469.1%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.9 88.7%   
Return on assets %11.05.4 204.9%  
Return on equity %14.810.0 148.0%  
Return on capital %20.013.3 149.8%  
Exports to sales %48.746.4 105.1%   
Imports to sales %7.114.2 49.7%   
Exports (fob) Rs m6,1155,622 108.8%   
Imports (cif) Rs m8891,728 51.4%   
Fx inflow Rs m6,1695,843 105.6%   
Fx outflow Rs m1,2852,173 59.1%   
Net fx Rs m4,8843,669 133.1%   
CASH FLOW
From Operations Rs m1,397398 351.3%  
From Investments Rs m-320-1,635 19.6%  
From Financial Activity Rs m-1,1961,309 -91.4%  
Net Cashflow Rs m-10271 -143.7%  

Share Holding

Indian Promoters % 55.4 39.2 141.3%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 3.6 94.2%  
FIIs % 3.9 17.6 22.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 39.6 93.4%  
Shareholders   30,437 20,750 146.7%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ALEMBIC LTD  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SUN PHARMA  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Sep 25, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - TORRENT PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS